FAAS
TBIO

First Allied Advisory Services’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

First Allied Advisory Services’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-19,000
Closed -$155K – 1262
2019
Q4 		$155K Buy
19,000
+6,000
+46% +$55.4K 0.01% 1153
2019
Q3 		$129K Buy
+13,000
New +$123K ﹤0.01% 1183

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Allied Advisory Services's TBIO Position: Q1 2020 in Review

First Allied Advisory Services sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2020, closing a stake of 19,000 shares — an estimated $155K sold.

First Allied Advisory Services first reported a position in TBIO in Q3 2019 and held it in 2 quarters. The position peaked at $155K in Q4 2019. 74 funds tracked by Wall St. Rank hold TBIO as of Q1 2020.

  • First Allied Advisory Services reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • First Allied Advisory Services sold 19,000 Translate Bio, Inc. Common Stock shares in Q1 2020, an estimated $155K.
  • First Allied Advisory Services first reported a position in Translate Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • First Allied Advisory Services's Translate Bio, Inc. Common Stock position peaked at $155K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2020.

Based on First Allied Advisory Services's 13F filing for Q1 2020, filed 8 May 2020.